BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35650563)

  • 1. Significance of tumor heterogeneity of p-Smad2 and c-Met in HER2-positive gastric carcinoma with lymph node metastasis.
    Tsujio G; Maruo K; Yamamoto Y; Sera T; Sugimoto A; Kasashima H; Miki Y; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
    BMC Cancer; 2022 Jun; 22(1):598. PubMed ID: 35650563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of
    Tsujio G; Yashiro M; Sakuma T; Aoyama R; Maruo K; Yamamoto Y; Maeda K
    Anticancer Res; 2023 Oct; 43(10):4359-4364. PubMed ID: 37772583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.
    Wu JG; Yu JW; Wu HB; Zheng LH; Ni XC; Li XQ; Du GY; Jiang BJ
    BMC Res Notes; 2014 Jan; 7():6. PubMed ID: 24393368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer].
    Chen L; Wei S; Ye Z; Zeng Y; Zheng Q; Xiao J; Wang Y; Zhuo C; Lin Z; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):218-223. PubMed ID: 28226359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer.
    Ajisaka H; Fushida S; Yonemura Y; Miwa K
    Hepatogastroenterology; 2001; 48(42):1788-92. PubMed ID: 11813625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients.
    Pereira MA; Ramos MFKP; Dias AR; Cardili L; Ribeiro RRE; de Castria TB; Zilberstein B; Nahas SC; Ribeiro U; de Mello ES
    Med Sci (Basel); 2021 Dec; 10(1):. PubMed ID: 35076580
    [No Abstract]   [Full Text] [Related]  

  • 8. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
    Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
    Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-135 inhibits gastric cancer metastasis by targeting SMAD2.
    He Y; Wu L; Dai Y; Li J; Liu S
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9436-9444. PubMed ID: 31773690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
    Li Y; Chen CQ; He YL; Cai SR; Yang DJ; He WL; Xu JB; Zan WH
    J Surg Oncol; 2012 Sep; 106(3):304-10. PubMed ID: 22231933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prognostic research of expression and relationship between Helicobacter pylori of c-met oncogene correlation with gastric mucosal proliferation].
    Zhuang X; Lin S; Zheng J; Wang L; Sun G; Li Y
    Zhonghua Nei Ke Za Zhi; 2001 Jun; 40(6):381-4. PubMed ID: 11798602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.
    Nagatsuma AK; Aizawa M; Kuwata T; Doi T; Ohtsu A; Fujii H; Ochiai A
    Gastric Cancer; 2015 Apr; 18(2):227-38. PubMed ID: 24626858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses.
    Shiraishi N; Inomata M; Osawa N; Yasuda K; Adachi Y; Kitano S
    Cancer; 2000 Jul; 89(2):255-61. PubMed ID: 10918153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of gut microbiota in patients with gastric cancer by surgery, chemotherapy and lymph node metastasis.
    Chen C; Shen J; Du Y; Shi X; Niu Y; Jin G; Liu Y; Shi Y; Lyu J; Lin L
    Clin Transl Oncol; 2022 Nov; 24(11):2181-2190. PubMed ID: 35794453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy.
    Ha SY; Lee J; Jang J; Hong JY; Do IG; Park SH; Park JO; Choi MG; Sohn TS; Bae JM; Kim S; Kim M; Kim S; Park CK; Kang WK; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1629-35. PubMed ID: 25157953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and clinical significance of lymph node metastasis-related genes within esophagogastric junction adenocarcinoma.
    Han R; Chen G; Li M; Peng ZM; Xu L
    Cancer Med; 2021 Aug; 10(15):5088-5100. PubMed ID: 34152098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of MET mRNA expression in gastric cancers using RNA in situ hybridization assay: its clinical implication and comparison with immunohistochemistry and silver in situ hybridization.
    Choi J; Lee HE; Kim MA; Jang BG; Lee HS; Kim WH
    PLoS One; 2014; 9(11):e111658. PubMed ID: 25364819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis.
    Noda S; Yashiro M; Toyokawa T; Morimoto J; Shinto O; Muguruma K; Sawada T; Hirakawa K
    Ann Surg Oncol; 2011 Dec; 18(13):3718-25. PubMed ID: 21573834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.